NCT04784689View on ClinicalTrials.gov

Host Immune Response to Novel RNA COVID-19 Vaccination

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

May 18, 2022

Study Completion Date

May 18, 2022

Conditions
COVID-19 VaccineCancer
Interventions
BIOLOGICAL

COVID-19 Vaccine

COVID-19 Vaccine

Trial Locations (1)

78229

Mays Cancer Center, UT Health San Antonio, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT04784689 - Host Immune Response to Novel RNA COVID-19 Vaccination | Biotech Hunter | Biotech Hunter